ValiRx plc (LON:VAL – Get Free Report)’s stock price shot up 17.4% during trading on Tuesday . The stock traded as high as GBX 0.50 ($0.01) and last traded at GBX 0.50 ($0.01). 10,318,630 shares changed hands during mid-day trading, an increase of 33% from the average session volume of 7,762,516 shares. The stock had previously closed at GBX 0.43 ($0.01).
ValiRx Trading Down 1.0 %
The firm has a market capitalization of £1.97 million, a price-to-earnings ratio of -0.35 and a beta of 0.59. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.27 and a current ratio of 6.65. The company has a 50-day moving average price of GBX 0.61 and a 200-day moving average price of GBX 1.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Joby Aviation: Operational Momentum vs. Market Sentiment
- Stock Splits, Do They Really Impact Investors?
- Broadcom’s Big Outperformance Shows Strength Amid Tariff Decline
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Carvana: Can Turnaround Strength Outdrive Market Headwinds?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
